CEP290 Antikörper (Internal Region)

Produktnummer ABIN334371

Produktdetails anti-CEP290 Antikörper

Target: CEP290 (Centrosomal Protein 290kDa (CEP290))

Bindungsspezifität: Internal Region

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser CEP290 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Verwendungszweck: CEP290 / NPHP6

Sequenz: QSGAESTIPD ADQ

Kreuzreaktivität: Human

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence C-QSGAESTIPDADQ, from the internal region of the protein sequence according to NP_079390.3.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Immunohistochemistry: Paraffin embedded Human Prostate. Recommended concentration: 4-8 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:8000.

Kommentare:

Immunofluorescence: Strong expression of the protein seen within the centrosome of HeLa cells. Recommended concentration: 10μg/ml.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu CEP290

Target: CEP290 (Centrosomal Protein 290kDa (CEP290))

Andere Bezeichnung: CEP290 (CEP290 Produkte)

Synonyme: ct87 antikoerper, mks4 antikoerper, rd16 antikoerper, bbs14 antikoerper, jbts5 antikoerper, jbts6 antikoerper, lca10 antikoerper, nphp6 antikoerper, slsn6 antikoerper, sh11ag antikoerper, MGC81471 antikoerper, 3h11ag antikoerper, RGD1311640 antikoerper, BC004690 antikoerper, Nphp6 antikoerper, b2b1454Clo antikoerper, b2b1752Clo antikoerper, im:7145703 antikoerper, im:7147820 antikoerper, 3H11Ag antikoerper, BBS14 antikoerper, CT87 antikoerper, JBTS5 antikoerper, LCA10 antikoerper, MKS4 antikoerper, NPHP6 antikoerper, POC3 antikoerper, SLSN6 antikoerper, centrosomal protein 290 antikoerper, centrosomal protein 290 L homeolog antikoerper, centrosomal protein 290kDa antikoerper, CEP290 antikoerper, cep290.L antikoerper, cep290 antikoerper, Cep290 antikoerper

Hintergrund: CEP290, centrosomal protein 290 kDa, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, monoclonal antibody 3H11 antigen, nephrocystin 6, nephrocystin-6, nephrocytsin-6, prostate cancer antigen T2

Gen-ID: 80184

NCBI Accession: NP_079390

Pathways: cAMP Metabolic Process, M Phase